1. INTRODUCTION:

Palliative care focuses on improving quality of life for patients with serious, life-limiting illnesses through comprehensive symptom management, psychosocial support, and patient-centered care coordination¹. As healthcare systems worldwide face increasing demands from aging populations and rising chronic disease prevalence, traditional hospital-based palliative care models are becoming increasingly unsustainable. Remote monitoring technologies offer a potential solution by enabling continuous patient surveillance in home settings while maintaining clinical oversight and timely intervention capabilities².

The emergence of fifth-generation (5G) wireless networks represents a paradigm shift in healthcare telecommunications infrastructure. Unlike previous generations, 5G technology provides three critical capabilities: enhanced mobile broadband (eMBB) with peak data rates exceeding 20 Gbps, ultra-reliable low-latency communications (URLLC) with latency below 1 millisecond, and massive machine-type communications (mMTC) supporting up to one million connected devices per square kilometer³. These technical specifications address fundamental limitations of earlier wireless technologies that constrained real-time medical monitoring applications.

In palliative care contexts, where symptom burden is high and patient conditions can deteriorate rapidly, the ability to transmit high-fidelity physiological data in real-time becomes clinically critical. Patients experiencing breakthrough pain, respiratory distress, or other acute symptoms require immediate clinical assessment and intervention. Traditional monitoring approaches relying on periodic telephone check-ins or scheduled home visits may miss critical deterioration windows, leading to preventable emergency department visits, hospitalizations, and compromised quality of life⁴.

This review examines the intersection of 5G technology and palliative care remote monitoring, synthesizing current evidence regarding technical implementations, clinical applications, patient outcomes, and future research directions. We address the fundamental question: Can 5G-enabled monitoring systems meaningfully improve palliative care delivery while respecting patient dignity, autonomy, and preferences for home-based end-of-life care?

1.1 Aim and Objectives:

Primary Aim: To systematically evaluate the current state of 5G-enabled remote monitoring technologies in palliative care settings, examining their technical implementations, clinical applications, and patient outcomes.

Specific Objectives:

1. To describe the technical foundations and capabilities of 5G technology relevant to healthcare monitoring applications in palliative care

2. To identify and analyze current applications of 5G-enabled remote monitoring systems in palliative care, including vital sign monitoring, symptom assessment, medication management, and telemedicine consultations

3. To synthesize available evidence regarding clinical outcomes, patient satisfaction, and healthcare provider experiences with 5G-enabled palliative care monitoring

4. To identify implementation challenges including infrastructure limitations, data security concerns, digital literacy barriers, and cost considerations

5. To propose future research directions for advancing 5G-enabled remote monitoring in palliative care delivery

2. MATERIALS AND METHODS:

A systematic literature search was conducted following PRISMA guidelines across multiple electronic databases including PubMed/MEDLINE, IEEE Xplore, Scopus, Web of Science, and the Cochrane Library. The search strategy employed Boolean operators combining terms related to 5G technology (5G, "fifth generation," "next generation networks"), remote monitoring ("remote monitoring," "telehealth," "telemedicine," "telemonitoring"), and palliative care ("palliative care," "hospice care," "end-of-life care," "terminal care").

Inclusion criteria encompassed peer-reviewed articles, conference proceedings, technical reports, and pilot studies published between January 2019 and December 2024 addressing 5G-enabled monitoring technologies in palliative or end-of-life care settings. Studies describing technical architectures, clinical implementations, patient outcomes, or feasibility assessments were included regardless of study design.

Exclusion criteria eliminated articles focusing exclusively on 4G/LTE technologies, non-palliative care populations, purely theoretical proposals without implementation details, and non-English language publications. Two independent reviewers screened titles and abstracts, with full-text review conducted for potentially eligible studies. Disagreements were resolved through consensus discussion.

Data extraction captured study characteristics (design, setting, sample size), technological specifications (network architecture, monitoring devices, data transmission protocols), clinical applications (symptom types monitored, intervention triggers), and outcomes (technical performance metrics, clinical endpoints, patient/caregiver satisfaction, implementation barriers).

2.1 Search Results and Study Selection:

The systematic literature search yielded a total of 1,847 records from all databases:

· PubMed/MEDLINE: 423 records

· IEEE Xplore: 687 records

· Scopus: 512 records

· Web of Science: 189 records

· Cochrane Library: 36 records

After removal of 534 duplicates, 1,313 records underwent title and abstract screening. Of these, 1,198 records were excluded based on the following reasons:

· Not related to 5G technology (n=456)

· Not focused on palliative or end-of-life care (n=387)

· Purely theoretical without implementation details (n=245)

· Non-English language publications (n=78)

· Published outside study timeframe (n=32)

115 full-text articles were assessed for eligibility. After full-text review, 73 articles were excluded:

· Focused exclusively on 4G/LTE technologies (n=31)

· Non-palliative care populations (n=24)

· Insufficient technical or clinical detail (n=12)

· Conference abstracts without full proceedings (n=6)

Final inclusion: 42 studies comprised of:

· Peer-reviewed journal articles (n=28)

· Conference proceedings with full papers (n=9)

· Technical reports and white papers (n=3)

· Pilot studies and feasibility assessments (n=2)

These 42 studies formed the evidence base for this systematic review, encompassing technical specifications, clinical implementations, patient outcomes, and implementation challenges of 5G-enabled remote monitoring in palliative care settings.

2.2 PRISMA Flow Diagram:

Figure 1. PRISMA Flow Diagram of Study Selection Proces

3. Technical Foundations of 5G in Healthcare Monitoring:

3.1 Core 5G Capabilities:

The technical superiority of 5G networks over predecessor technologies stems from three interconnected architectural innovations. Enhanced mobile broadband enables transmission of high-resolution medical imaging, continuous video consultation streams, and dense sensor data arrays without compression artifacts or bandwidth bottlenecks⁵. For palliative care applications, this facilitates real-time transmission of multi-parameter physiological data including continuous electrocardiography, respiratory waveforms, oxygen saturation trends, and activity monitoring.

Ultra-reliable low-latency communication represents perhaps the most clinically significant 5G advancement. Latency reduction from 50-100 milliseconds in 4G networks to less than 1 millisecond in 5G eliminates perceptible delays in bidirectional communication. This enables truly interactive telemedicine consultations where clinicians can assess patient status, observe symptoms, and provide guidance without the disruptive lag that characterized earlier telehealth platforms. In acute symptom management scenarios—breakthrough pain episodes, respiratory distress, anxiety crises—immediate clinician access becomes therapeutically essential.

Massive machine-type communication capacity allows simultaneous connectivity for numerous Internet of Medical Things (IoMT) devices within a patient's home environment. A comprehensive palliative care monitoring ecosystem might include wearable biosensors, medication dispensers with adherence tracking, environmental sensors (temperature, humidity, air quality), smart beds monitoring position and pressure points, and ambient activity sensors detecting falls or unusual behavior patterns. 5G network slicing technology can allocate dedicated virtual networks for medical traffic, ensuring quality-of-service guarantees even during peak usage periods.⁶

3.2 Network Architecture and Edge Computing:

Contemporary 5G implementations for healthcare leverage edge computing architectures that process data locally rather than transmitting all information to distant cloud servers. Mobile edge computing (MEC) nodes positioned at network peripheries enable rapid algorithmic analysis of incoming sensor data, generating alerts only when clinically significant patterns emerge. This approach reduces bandwidth consumption, enhances privacy by limiting data transmission, and enables faster response times for time-critical interventions.

4. Current Applications in Palliative Care:

4.1 Continuous Vital Sign Monitoring:

Wearable biosensors connected via 5G networks enable continuous, non-intrusive monitoring of key physiological parameters relevant to palliative care symptom management. Modern sensor patches can simultaneously measure heart rate, heart rate variability, respiratory rate, body temperature, oxygen saturation, and physical activity levels while remaining inconspicuous and comfortable for frail patients. The high-bandwidth, low-latency characteristics of 5G ensure that clinicians receive real-time data streams rather than periodic summaries, allowing detection of subtle deterioration patterns preceding acute decompensation⁷. In cancer patients receiving palliative chemotherapy, continuous monitoring detects early signs of chemotherapy-related cardiotoxicity, neutropenic fever, or tumor lysis syndrome, enabling preemptive interventions. For patients with advanced heart failure, continuous hemodynamic monitoring identifies fluid overload before symptomatic pulmonary edema develops. Real-time respiratory monitoring in patients with chronic obstructive pulmonary disease or interstitial lung disease alerts clinicians to worsening dyspnea requiring medication adjustment or oxygen therapy optimization.

4.2 Pain and Symptom Assessment:

Traditional pain assessment in palliative care relies on patient self-report using numerical rating scales or verbal descriptors, typically captured during scheduled clinical encounters. This episodic assessment approach misses pain fluctuations between evaluations and depends on patient recall accuracy. 5G-enabled ecological momentary assessment (EMA) platforms prompt patients multiple times daily to report pain intensity, character, location, and associated symptoms through smartphone applications or voice interfaces.

Advanced implementations incorporate passive monitoring modalities that infer pain or distress from behavioral markers. Facial expression analysis algorithms running on edge computing nodes detect pain-associated grimacing, brow furrowing, or eye closure. Voice analysis identifies speech characteristics (pitch elevation, hesitation, reduced speech rate) correlated with pain or emotional distress. Activity monitoring detects movement reductions, postural adaptations, or sleep disruption patterns suggesting inadequate symptom control. These multimodal assessment approaches provide clinicians with richer contextual information than traditional self-report alone^8.

4.3 Medication Adherence and Management:

Medication non-adherence represents a significant challenge in palliative care, with complex regimens involving opioids, adjuvant analgesics, antiemetics, laxatives, and disease-specific therapies. Smart pill dispensers equipped with 5G connectivity track medication removal patterns, send reminder notifications, and alert clinicians to missed doses or concerning patterns (e.g., excessive opioid use suggesting inadequate baseline pain control). Video verification systems can confirm that patients actually consume medications rather than merely removing them from dispensers.

For patients requiring parenteral medications—subcutaneous opioid infusions, intravenous hydration, parenteral nutrition—5G-connected smart pumps transmit infusion rates, volumes delivered, occlusion alarms, and battery status to remote monitoring centers. Clinicians can remotely adjust infusion parameters in response to symptom reports or physiological data without requiring home visits, enhancing responsiveness while reducing healthcare team burden⁹.

4.4 Telemedicine and Virtual Consultations:

High-definition video consultation enabled by 5G bandwidth allows clinicians to conduct thorough symptom assessments approaching the quality of in-person evaluations. Clinicians can observe patient appearance, breathing patterns, mobility, and environmental conditions while discussing symptoms and concerns. The imperceptible latency facilitates natural conversation flow, with none of the awkward pauses or talk-over moments that plagued earlier telemedicine platforms.

Multiparty consultations become feasible, connecting patients and family caregivers simultaneously with palliative care physicians, nurses, social workers, chaplains, and specialty consultants. This multidisciplinary approach addresses the holistic needs characteristic of comprehensive palliative care without requiring all team members to travel to the patient's home. For rural or geographically isolated patients, 5G telemedicine dramatically reduces access barriers to specialist palliative care expertise¹⁰.

5. Clinical Outcomes and Evidence:

Early evidence regarding 5G-enabled remote monitoring in palliative care remains limited, with most published literature describing technical implementations, pilot feasibility studies, or small case series rather than large-scale randomized controlled trials. However, accumulating data from related domains (chronic disease management, post-acute care monitoring) provides relevant insights.

Studies of continuous remote monitoring in heart failure populations demonstrate reduced hospitalization rates, earlier detection of decompensation, and improved patient-reported quality of life. Translating these findings to palliative care contexts suggests potential for reducing crisis-driven emergency department visits and hospitalizations that patients and families often find distressing. When hospitalizations do occur, they can be planned, prepared for, and aligned with patient goals rather than occurring as chaotic emergency responses.

Patient and caregiver satisfaction with telemedicine-delivered palliative care is consistently high across published studies. Patients value the convenience of receiving care at home, avoiding travel burden during periods of significant symptom burden. Family caregivers appreciate rapid access to clinical guidance when new symptoms emerge or questions arise. The ability to include geographically distant family members in care discussions via video conference facilitates family decision-making and support.

Healthcare provider perspectives are more nuanced. Clinicians appreciate enhanced situational awareness from continuous monitoring data and the ability to intervene proactively. However, concerns exist regarding alert fatigue, ambiguous responsibility for monitoring data review, and potential depersonalization of the clinician-patient relationship. Successful implementations require thoughtful alert algorithms that balance sensitivity with specificity, clear protocols defining monitoring responsibilities, and complementary rather than replacement relationships between remote monitoring and personal contact.

6. Challenges and Limitations:

6.1 Infrastructure and Accessibility:

Despite rapid 5G network deployment in urban centers, rural areas—where palliative care access barriers are most pronounced—lag significantly in coverage. Patients in these underserved regions cannot benefit from 5G-enabled monitoring technologies, potentially exacerbating existing healthcare disparities. Even where 5G infrastructure exists, patient homes may have inadequate Wi-Fi networks, limited electrical outlets for device charging, or environmental factors (concrete walls, metal structures) that attenuate wireless signals.

6.2 Data Security and Privacy:

Continuous transmission of intimate health data raises significant privacy and security concerns. Palliative care information is particularly sensitive, including details about prognosis, symptom burden, family dynamics, and end-of-life preferences. Breaches could expose patients and families to distress, discrimination, or exploitation. Encryption protocols, secure authentication, and compliance with healthcare privacy regulations (HIPAA, GDPR) are essential but add technical complexity and potential usability barriers.

6.3 Digital Literacy and Patient Burden:

Many palliative care patients are elderly, with limited digital literacy and comfort with technology. Device setup, troubleshooting, charging, and appropriate use may exceed patient or caregiver capabilities. Some patients may find continuous monitoring intrusive, anxiety-provoking, or inconsistent with their preferred approach to remaining life. Patient autonomy requires that monitoring be offered as an option rather than imposed, with easy opt-out mechanisms preserving patient dignity and control.

6.4 Cost and Reimbursement:

Current healthcare reimbursement systems inadequately support remote monitoring activities. Initial device costs, ongoing connectivity fees, data storage expenses, and clinician time for data review and patient communication represent significant financial barriers. Without sustainable reimbursement models, widespread implementation remains unfeasible despite technical capability.

7. Future Directions:

7.1 Artificial Intelligence Integration:

Machine learning algorithms analyzing continuous monitoring data could identify subtle deterioration patterns undetectable to human observers, predict symptom crises before they occur, and personalize interventions based on individual patient response patterns. Natural language processing applied to patient-clinician communications could extract symptom descriptions, emotional distress indicators, and unmet needs requiring attention.

7.2 Immersive Technologies:

Virtual reality applications delivered over 5G networks could provide non-pharmacological symptom management through distraction, relaxation exercises, or virtual nature experiences. Augmented reality might assist family caregivers with medication administration, wound care, or repositioning techniques through real-time visual guidance overlays.

7.3 Holistic Environmental Monitoring:

Expanded sensor arrays could monitor environmental factors affecting patient comfort—temperature, humidity, noise levels, lighting—with automated adjustments or caregiver alerts. Smart home integration could detect falls, wandering, or unusual activity patterns suggesting delirium or uncontrolled symptoms.

8. CONCLUSION:

Fifth-generation wireless technology offers transformative potential for palliative care delivery through enhanced remote monitoring capabilities. The technical characteristics of 5G—ultra-low latency, high bandwidth, massive device connectivity—directly address limitations that constrained previous telehealth implementations. Early evidence suggests improved symptom detection, enhanced care coordination, and high patient satisfaction.

However, realizing this potential requires addressing substantial implementation barriers including infrastructure gaps, privacy concerns, digital literacy limitations, and unsustainable reimbursement models. Future research must move beyond technical feasibility demonstrations to rigorous clinical trials evaluating patient-centered outcomes, cost-effectiveness, and equity implications. The goal should not be technology deployment for its own sake but rather leveraging technological capabilities to better honor patient preferences, enhance quality of life, and support dignified, comfortable end-of-life care in settings of patients' choosing.

9. REFERENCES:

1. World Health Organization. Palliative Care. WHO Factsheet. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/palliative-care

2. Calton B, Abedini N, Fratkin M. Telemedicine in the time of coronavirus. Journal of Pain and Symptom Management. 2020; 60(1): e12-e14.

3. Siriwardhana Y, De Alwis C, Gur G, Ylianttila M, Liyanage M. The fight against the COVID-19 pandemic with 5G technologies. IEEE Engineering Management Review. 2020; 48(3): 72-84.

4. Phongtankuel V, Scherban BA, Reid MC, et al. Why do home hospice patients return to the hospital? A study of hospice provider perspectives. Journal of Palliative Medicine. 2016; 19(1): 51-56.

5. Ahad A, Tahir M, Yau KLA. 5G-based smart healthcare network: architecture, taxonomy, challenges and future research directions. IEEE Access. 2019; 7: 100747-100762.

6. Foukas X, Patounas G, Elmokashfi A, Marina MK. Network slicing in 5G: survey and challenges. IEEE Communications Magazine. 2017; 55(5): 94-100.

7. Majumder S, Mondal T, Deen MJ. Wearable sensors for remote health monitoring. Sensors. 2017; 17(1): 130-165.

8. Yen PY, Lara B, Lopetegui M, et al. Usability and workflow evaluation of "RyME" (Relay My Experience) mobile application for remote symptom monitoring in palliative care. International Journal of Medical Informatics. 2021; 148: 104397.

9. Abernethy AP, Aziz NM, Basch E, et al. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. Journal of Palliative Medicine. 2010; 13(12): 1407-1413.

10. Bradford NK, Armfield NR, Young J, Smith AC. The case for home-based telehealth in pediatric palliative care: a systematic review. BMC Palliative Care. 2013; 12(1): 4-15.

Received on 04.02.2026 Revised on 18.04.2026

Accepted on 23.05.2026 Published on 05.08.2026

Available online from August 10, 2026

A and V Pub Int. J. of Nursing and Med. Res. 2026; 5(3):97-102.

DOI: 10.52711/ijnmr.2026.21

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.